Category: Molecular Biology
United States Molecular Biology
-
Exosome Research Products
... by 2030, growing at a CAGR of 20.6% over the analysis period 2023-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.3% CAGR and reach US$697.8 Million ... Read More
-
Pyrogen Testing
... at a CAGR of 10.5% over the analysis period 2023-2030. Assays, Kits & Reagents, one of the segments analyzed in the report, is expected to record a 11.1% CAGR and reach US$1.1 Billion by the ... Read More
-
US Esoteric Testing Market Size study, by Type (Oncology testing, Infectious disease testing, Genetic testing, Endocrinology testing, Toxicology testing, Neurology testing, Others), By Technology (Chemiluminescence immunoassay, Enzyme-linked immunosorbent assay, Mass spectrometry, Real time polymerase chain reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032
... reaction, Flow cytometry, Other), By End Use (Hospital-based laboratories, Independent and reference laboratories, Others) Forecasts 2022-2032 US Esoteric Testing Market is valued approximately USD 6.87 Billion in 2023 and is anticipated to grow with a ... Read More
-
United States Food Allergen Testing Market Forecast Report By Food Testing (Meat and Seafood, Dairy Products, Bakery and Confectionery, Baby Food and Infant Formula, Beverages, Other Processed Foods), Technology (PCR, Biosensors-based, Immunoassay-based/ELISA, Other Technologies), States and company analysis 2024-2032
... and company analysis 2024-2032 United States Food Allergen Testing Market Analysis The United States Food Allergen Testing Market will reach US$ 422.67 Million by 2032, up from US$ 229.90 Million in 2023, with a CAGR ... Read More
-
US Influenza Diagnostics Market Size study, by Test Type (RIDT, RT-PCR, Cell Culture, Others), by End Use (Hospitals, POCT, Laboratories) Forecasts 2022-2032
... and is anticipated to grow with a healthy growth rate of more than 5.86 % over the forecast period 2024-2032. Influenza diagnostics encompass the range of methods and tools employed for identifying and diagnosing influenza ... Read More
-
United States Molecular Diagnostics Market Report by Technology (Chips and Microarrays, In Situ Hybridization, Sequencing, Mass Spectrometry (MS), PCR, and Other Technologies), Application (Pharmacogenomics, Infectious Disease, Genetic Disease Screening, Oncology, Blood Screening, Microbiology, and Human Leukocyte Antigen Typing), Product (Instruments, Reagents, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Company Analysis 2024-2032
... Leukocyte Antigen Typing), Product (Instruments, Reagents, and Other Products), End User (Hospitals, Laboratories, and Other End Users), and Company Analysis 2024-2032 The United States Molecular Diagnostics Market was US$ 7.98 billion in 2023 and will ... Read More
-
US Gene Expression Analysis Market Size study, by Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Microarrays, Others), by Product Type (Instruments, Reagents and Consumables, Services), by End-user (Drug Discovery & Development, Diagnostic Laboratories, Academic Research Centers) Forecasts 2022-2032
... Academic Research Centers) Forecasts 2022-2032 US Gene Expression Analysis Market is valued at approximately USD XX million in 2023 and is anticipated to grow with a healthy growth rate of more than XX % over ... Read More
-
United States Pyrogen Testing Market: Prospects, Trends Analysis, Market Size and Forecasts up to 2032
... States market. Moreover, the report provides deep insights into demand forecasts, market trends, and, micro and macro indicators in the United States market. Also, factors that are driving and restraining the pyrogen testing market are ... Read More
-
United States Liquid Biopsy Market Report by Cancer types (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Liver Cancer, and Other Cancer), Products (Kits & Reagents, Platforms & Instruments, and Services), Application (Early Diagnosis, Patient Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research Centers), and Company Analysis 2024-2032
... Monitoring, and Recurrence Monitoring), Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (ctDNA), Extracellular Vesicles (EVs), and Other Biomarker Types), Sample types (Blood, Urine, and Others), End-Users (Hospitals & Laboratories and Governments & Academic Research ... Read More
-
North America Cancer Biopsy Market, By Product (Instruments, Kits and Consumables, Services), By Type (Tissue Biopsy, Surgical Biopsy, Liquid Biopsy, Others), By Application (Breast Cancer, Colorectal Cancer, Cervical Cancer, Lung Cancers, Others (Including Liver Cancer, Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030
... Blood Cancer, Prostate Cancer)), By End User (Hospitals, Diagnostic Laboratories, Others), By Country (United States, Canada), Trend Analysis, Competitive Landscape & Forecast, 2019–2030 North America Cancer Biopsy Market Size Set Expands at Significant CAGR of ... Read More
-
U.S. Influenza Diagnostics Market Size, Share & Trends Analysis Report By Test Type (RIDT, RT-PCR, Cell Culture, Others), By End-use (Hospitals, POCT, Laboratories), And Segment Forecasts, 2023 - 2030
... Trends The U.S. influenza diagnostics market size is expected to reach USD 282.9 million by the year 2030 growing at a CAGR of 5.9% according to a new report by Grand View Research, Inc. Key ... Read More
-
U.S. Early Toxicity Testing Market by Technique (In Vivo, In Vitro, and In Silico), by Toxicity Endpoint (Genotoxicity, Dermal Toxicity, Skin Toxicity, Ocular Toxicity, Phototoxicity, and Others), by End User (Pharmaceutical Industry, Cosmetic Industry, Chemical Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030
... Industry, Food Industry, and Others) – Opportunity Analysis and Industry Forecast, 2023-2030 U.S. Early Toxicity Testing Market was valued at USD 2.42 billion in 2022, and is predicted to reach USD 4.14 billion by 2030, ... Read More
-
U.S. Carrier Screening Market on the basis of Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others) and End User (Hospitals & Clinics, Reference Laboratories, Physician Offices and Others) Forecast up to 2027
... Offices and Others) Forecast up to 2027 U.S. Carrier Screening Market on the basis of Type (Expanded Carrier Screening and Targeted Disease Carrier Screening), Technology (DNA Sequencing, Polymerase Chain Reaction, Microarrays and Others) and End ... Read More
-
United States Life Science Tools Market Assessment, By Type [Instruments, Consumables, Services], By Technology [Genomics, Proteomics, Cell Biology Technology, Lab Supplies, Others], By Product [Cell Culture Systems & 3D Cell Culture, Liquid Chromatography, Mass Spectrometry, Flow Cytometry, Cloning & Genome Engineering, Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing, Transfection Device & Gene Delivery Technologies, Nuclear Magnetic Resonance, Others], By End-user [Healthcare, Government & Academic Institutions, Biopharmaceutical Company, Industrial Applications, Others], By Region, Opportunities and Forecast, 2016-2030F
... Flow Cytometry, Cloning & Genome Engineering, Microscopy, Next Generation Sequencing, PCR & qPCR, Nucleic Acid Preparation, Nucleic Acid Microarray, Sanger Sequencing, Transfection Device & Gene Delivery Technologies, Nuclear Magnetic Resonance, Others], By End-user [Healthcare, Government ... Read More
-
United States Solid Tumor Testing Market, By Type (Conventional Testing, Non-Conventional Testing (Fluorescence in-situ hybridization (FISH), Immunohistochemistry (IHC), Polymerase chain reaction (PCR), and Next-generation sequencing (NGS)); By Cancer Type (Prostate, Breast, Endometrial, Lung, Brain, Others); By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic Research Institutes), Trend Analysis, Competitive Landscape & Forecast, 2019–2029
... By End User (Hospitals, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Academic Research Institutes), Trend Analysis, Competitive Landscape & Forecast, 2019–2029 United States Solid Tumor Testing Market Size Expanding to Reach USD 10.3 Billion ... Read More
-
U.S. Monkeypox Testing Market – Industry Outlook & Forecast 2023-2025
... is projected to register a CAGR of (74.26%) during the forecast period. Monkeypox is an orthopoxviral related to the smallpox virus and initially affected the U.S. population in 2003. Cases of monkeypox increased at the ... Read More
-
NA Transfection Reagents and Equipment Market - Industry Trends and Forecast to 2030
... to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022 and the forecast period is 2023 to 2030. Market Segmentation: North America Transfection Reagents and ... Read More
-
NA Exosome Research Products Market - Industry Trends And Forecast To 2030
... The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030. Market Segmentation: North America Exosome Research Products Market, By ... Read More
-
U.S. Polymerase Chain Reaction Market - Industry Trends and Forecast to 2030
... CAGR of 12.2% during the forecast period of 2023 to 2030. Market Segmentation By Product Type (Reagents, Instruments, Consumables, Software, and Services), Method (Real-Time PCR, Reverse-Transcriptase (RT) PCR, Conventional PCR, Multiplex PCR, Nested PCR, Hot ... Read More
-
United States Liquid Biopsy Market Revenue and Forecast to 2028-Segmentation by Biomarker Type, by Products, by Therapeutic Application, by Cancer Type, by Cities
... between 3%-6% in last five years and despite of disturbances in the year 2020 the market witnessed a positive growth, owing to the increasing number of cancer patients and liquid biopsy being on introduction stage. ... Read More
-
United States Liquid Biopsy Market Revenue and Forecast to 2028
... 2020 the market witnessed a positive growth, owing to the increasing number of cancer patients and liquid biopsy being on introduction stage. The market is expanding as a result of the rising incidence of cancer ... Read More
-
United States Liquid Biopsy Market, Size, Global Forecast 2022-2027, Industry Trends, Growth, Outlook, Impact of COVID-19, Company Analysis
... the molecular examination of nucleic acids, subcellular structures, particularly exosomes, and, in the case of cancer, circulating tumor cells in bodily fluids. Liquid biopsy has been the subject of intense research over the last ten ... Read More
-
United States Genetic Testing Market, By Type (Predictive & Presymptomatic Testing, Carrier Testing, Prenatal & Newborn Testing, Diagnostic Testing, Pharmacogenomic Testing, Others), By Technique (PCR, DNA Sequencing, Microarrays, Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, Others), By End-User (Hospitals, Independent Laboratories, Others), By Payers (Public Health Insurance, Private Health Insurance, and Others)Trend Analysis, Competitive Market Share & Forecast, 2018-2028
... Dysfunction, Pathogenomics, Others), By End-User (Hospitals, Independent Laboratories, Others), By Payers (Public Health Insurance, Private Health Insurance, and Others)Trend Analysis, Competitive Market Share & Forecast, 2018-2028 United States Genetic Testing Market to Cross USD 12 ... Read More
-
United States Liquid Biopsy Market, By Product & Services (Assay Kits, Instruments, Services), By Circulating Biomarker (Circulating Tumor Cells, Circulating Tumor DNA (ctDNA), Cell-free DNA (cfDNA), Others), By Technology (Multi-gene Parallel Analysis using NGS v/s Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027
... Single-gene Analysis using PCR Microarrays), By Application (Cancer v/s Non-Cancer), By End User (Hospitals & Clinics, Reference Laboratories, Others), By Region, Competition Forecast & Opportunities, 2027 The United States liquid biopsy market is projected to ... Read More
-
U.S., Europe, and Asia Pacific Molecular Diagnostics Market, by Product Type (Reagents and Kits & Instruments), by Technology (PCR-based (Liquid Biopsy Testing, Tissue Testing) and NGS-based (Liquid Biopsy Testing, Tissue Testing)), by Application, (Genet
... Oncology, Microbiology, STDs, Blood Screening, Virology, Tissue Typing, Prenatal Diagnosis, Others), by End Users, (Hospitals, Clinics, and Ambulatory Surgery Centers), and by Region (U.S., Europe, and Asia Pacific) - Size, Share, Outlook, and Opportunity Analysis, ... Read More
Research Assistance
